Changes in Pulmonary and Cerebral Blood Flow After Surfactant Treatment for Severe Respiratory Distress Syndrome
Neonatal respiratory distress syndrome remains a major cause of death and disability in babies. Death is often associated with development of acute complications such as pneumothorax and intraventricular haemorrhage (IVH). Long term disability may result from the sequelae of IVH or bronchopulmonary dysplasia.
KeywordsSurfactant Peri Indomethacin Pneumothorax Berman
Unable to display preview. Download preview PDF.
- 1.Collaborative European Multicentre Group (1987) An international randomized clinical trial of surfactant replacement therapy in severe neonatal respiratory distress syndrome. Eur J Respir DisGoogle Scholar
- 2.McCord B, Curstedt T, Halliday HL, McClure G, Reid MMcC, Robertson B (1987) Surfactant treatment reduces the incidence of intraventricular haemorrhage in severe respiratory distress syndrome. Arch Dis ChildGoogle Scholar
- 5.Philip AGS (1985) Symposium on non-invasive neonatal diagnosis. Clin Perinatol 12: 181–182Google Scholar